Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
Aska Toda, Kenjiro Sawada, Akihiko Yoshimura, Erika Nakatsuka, Hiromasa Kuroda, Katsumi Kozasa, Mayuko Miyamoto, Kae Hashimoto, Seiji Mabuchi, Tadashi Kimura Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan Background: In clinical practice,...
Main Authors: | Toda A, Sawada K, Yoshimura A, Nakatsuka E, Kuroda H, Kozasa K, Miyamoto M, Hashimoto K, Mabuchi S, Kimura T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-11-01
|
Series: | International Journal of Women's Health |
Subjects: | |
Online Access: | https://www.dovepress.com/effects-of-minodronate-in-postmenopausal-women-with-osteoporosis-who-r-peer-reviewed-article-IJWH |
Similar Items
-
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
by: Masaki Kobayashi, et al.
Published: (2020-03-01) -
Minodronate for the treatment of osteoporosis
by: Ohishi T, et al.
Published: (2018-04-01) -
A review of minodronic acid hydrate for the treatment of osteoporosis
by: Tanishima S, et al.
Published: (2013-02-01) -
Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
by: Mizue Tanaka, et al.
Published: (2017-03-01) -
The effect of smoking on the response to raloxifene treatment in postmenopausal osteoporosis
by: Savaş Erdem, et al.
Published: (2012-12-01)